New hope for frail lung cancer patients: immunotherapy shows promise
NCT ID NCT04108026
First seen Nov 01, 2025 · Last updated May 16, 2026 · Updated 22 times
Summary
This study tested the drug durvalumab in 50 people with advanced stage IV non-small cell lung cancer who had poor overall health (ECOG 2-3) and had not received prior treatment. The goal was to see if the drug could control the cancer and be safe for these patients, who are often excluded from other trials. The approach uses the immune system to fight the cancer, but patients may need ongoing monitoring or additional treatment.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-SMALL CELL LUNG CANCER STAGE IV are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AP-HM Hopital Nord
Marseille, France
-
AP-HP Hopital Tenon - Pneumologie
Paris, 75020, France
-
Besançon - CHU
Besançon, France
-
CH
Colmar, France
-
CHR d'Orléans La Source
Orléans, France
-
CHRU Grenoble
Grenoble, France
-
CHRU de Lille
Lille, France
-
CHU Strasbourg
Strasbourg, France
-
CHU Toulouse - Pneumologie
Toulouse, France
-
CHU Tours - Pneumologie
Tours, France
-
Caen - CHU Côte de Nacre
Caen, 14000, France
-
Centre Hospitalier - Pneumologie
Le Mans, 72000, France
-
GRH Mulhouse Sud-Alsace
Mulhouse, France
-
Hôpital Ambroise Paré - Pneumologie
Boulogne, France
-
Lyon - URCOT
Pierre-Bénite, France
-
Montpellier - CHRU
Montpellier, 34295, France
-
Nancy - Institut de Cancérologie de Lorraine
Nancy, France
-
Nantes - ICO Site René Gauducheau
Nantes, 44805, France
-
Paris - APHP Bichat
Paris, France
-
Paris - Curie
Paris, France
Conditions
Explore the condition pages connected to this study.